"Le Centre de recherche du Centre hospitalier de l’Université de Montréal (CRCHUM) est le plus grand centre de recherche en sciences biomédicales et soins de santé de l’Université de Montréal, et parmi les plus imposants au Canada."

During the past decade, Centre de Recherche du CHUM conducted 49 clinical trials. In the 10-year time frame, 49 clinical trials started and 7 clinical trials were completed, i.e. on average, 14.3% percent of trials that started reached the finish line to date. In the past 5 years, 27 clinical trials started and 7 clinical trials were completed. i.e. 25.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Centre de Recherche du CHUM" #1 sponsor was "Centre hospitalier de l'Université de Montréal (CHUM)" with 12 trials, followed by "Gilead Sciences" with 6 trials sponsored, "Janssen Research & Development, LLC" with 4 trials sponsored, "Intercept Pharmaceuticals" with 3 trials sponsored and "Allena Pharmaceuticals" with 3 trials sponsored. Other sponsors include 26 different institutions and companies that sponsored additional 30 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centre de Recherche du CHUM" #1 collaborator was "Canadian Institutes of Health Research (CIHR)" with 8 trials as a collaborator, "Centre de Recherche du Centre Hospitalier de l'Université de Montréal" with 3 trials as a collaborator, "Drug Safety and Effectiveness Network, Canada" with 2 trials as a collaborator, "Pfizer" with 2 trials as a collaborator and "Alberta Prion Research Institute" with 1 trials as a collaborator. Other collaborators include 28 different institutions and companies that were collaborators in the rest 38 trials.

According to Clinical.Site data, the most researched conditions in "Centre de Recherche du CHUM" are "Amyotrophic Lateral Sclerosis" (3 trials), "Heart Failure" (3 trials), "All-cause Mortality" (2 trials), "Atrial Fibrillation" (2 trials) and "Cystic Fibrosis" (2 trials). Many other conditions were trialed in "Centre de Recherche du CHUM" in a lesser frequency.

Most popular intervention types in "Centre de Recherche du CHUM" are "Drug" (41 trials), "Other" (7 trials), "Procedure" (5 trials), "Device" (3 trials) and "Diagnostic Test" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (19 trials), "BI 685509" (2 trials), "Cetrelimab 480 mg" (2 trials), "PF-05221304" (2 trials) and "Reldesemtiv" (2 trials). Other intervention names were less common.

The vast majority of trials in "Centre de Recherche du CHUM" are 50 trials for "All" genders, 6 trials for "Male" genders and 2 trials for "Female" genders.

Currently, there are 26 active trials in "Centre de Recherche du CHUM". 1 are not yet recruiting, 13 are recruiting, 11 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 22 completed trials in Centre de Recherche du CHUM, 1 suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Centre de Recherche du CHUM, 4 "Phase 1" clinical trials were conducted, 22 "Phase 2" clinical trials and 15 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 12 trials that are defined as “Not Applicable".